Metropolitan Life Insurance Company (MetLife)’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,068
| Closed | -$8.99K | – | 2134 |
|
|
2024
Q1 | $8.99K | Sell |
4,068
-6
| -0.1% | -$13 | ﹤0.01% | 2166 |
|
|
2023
Q4 | $9.57K | Buy |
+4,074
| New | +$9.57K | ﹤0.01% | 2194 |
|
|
2023
Q2 | – | Sell |
-7,329
| Closed | -$11.9K | – | 2525 |
|
|
2023
Q1 | $11.9K | Sell |
7,329
-1,211
| -14% | -$1.97K | ﹤0.01% | 2092 |
|
|
2022
Q4 | $11.4K | Buy |
8,540
+6,740
| +374% | +$8.96K | ﹤0.01% | 2246 |
|
|
2022
Q3 | $2.81K | Sell |
1,800
-6,423
| -78% | -$10K | ﹤0.01% | 2308 |
|
|
2022
Q2 | $12.7K | Buy |
+8,223
| New | +$12.7K | ﹤0.01% | 2254 |
|
|
2020
Q4 | – | Sell |
-15,523
| Closed | -$92.1K | – | 2578 |
|
|
2020
Q3 | $92.1K | Buy |
+15,523
| New | +$92.1K | ﹤0.01% | 2263 |
|
|
2019
Q4 | – | Sell |
-10,158
| Closed | -$99.9K | – | 2562 |
|
|
2019
Q3 | $99.9K | Buy |
10,158
+7,943
| +359% | +$78.1K | ﹤0.01% | 2304 |
|
|
2019
Q2 | $25.3K | Buy |
+2,215
| New | +$25.3K | ﹤0.01% | 2577 |
|